0001599298-22-000127.txt : 20221117
0001599298-22-000127.hdr.sgml : 20221117
20221117162759
ACCESSION NUMBER: 0001599298-22-000127
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221115
FILED AS OF DATE: 20221117
DATE AS OF CHANGE: 20221117
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cesano Alessandra
CENTRAL INDEX KEY: 0001827015
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36866
FILM NUMBER: 221398721
MAIL ADDRESS:
STREET 1: 700 BALTIC CIRCLE, SUITE 716
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Summit Therapeutics Inc.
CENTRAL INDEX KEY: 0001599298
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2882 SAND HILL ROAD
STREET 2: SUITE 106
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 617-514-7149
MAIL ADDRESS:
STREET 1: 2882 SAND HILL ROAD
STREET 2: SUITE 106
CITY: MENLO PARK
STATE: CA
ZIP: 94025
FORMER COMPANY:
FORMER CONFORMED NAME: Summit Therapeutics plc
DATE OF NAME CHANGE: 20150219
FORMER COMPANY:
FORMER CONFORMED NAME: Summit Corp plc
DATE OF NAME CHANGE: 20140205
4
1
wf-form4_166872044673174.xml
FORM 4
X0306
4
2022-11-15
0
0001599298
Summit Therapeutics Inc.
SMMT
0001827015
Cesano Alessandra
C/O SUMMIT THERAPEUTICS INC.
2882 SAND HILL ROAD, SUITE 106
MENLO PARK
CA
94025
1
0
0
0
Stock Option (right to buy)
1.09
2022-11-15
4
A
0
200000
A
2032-11-15
Common Stock
200000.0
200000
D
Stock Option (right to buy)
1.09
2022-11-15
4
A
0
4166
A
2032-11-15
Common Stock
4166.0
204166
D
The option was granted on November 15, 2022. The shares underlying the option are scheduled to vest in four equal annual installments, with the first such installment occurring on November 15, 2023.
Not applicable.
The option was granted on November 15, 2022 and represents a pro rata amount of the annual 25,000 option board grant based approximately on the number of days the Reporting Person is anticipated to serve as a director. The shares underlying the option are scheduled to vest in full on December 31, 2022.
/s/ Ankur Dhingra, as Attorney-in-Fact for Alessandra Cesano
2022-11-17